Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Povidone-iodine plus levofloxacin before cataract surgery
IRCT20191023045211N1Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Nov 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of povidone-iodine and levofloxacin in cataract (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoint: Infection. Started Nov 2019; status: completed.
02
Drugs
povidone-iodinelevofloxacin
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20191023045211N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191023045211N1.